Selected Publications

Williams NO, Quiroga D, Johnson C, Brufsky A, Chambers M, Bhattacharya S, Patterson M, Sardesai SD, Stover D, Lustberg M, Noonan AM, Cherian M, Bystry DM, Hill KL, Chen M, Phelps MA, Grever M, Stephens JA, Ramaswamy B, Carson WE 3rd, Wesolowski R.: Phase Ib study of HSP90 inhibitor, onalespib (AT13387), in combination with paclitaxel in patients with advanced triple-negative breast cancer. Ther Adv Med Oncol. : 2023.

Russell J. Schilder, Mark S. Shahin, Mitchell Edelson, Norman G. Rosenblum, Ashley Douglas, Saveri Bhattacharya, Tarek Sahmoud, Elizabeth Burton, Avnish K Bhatia: OATH trial: A phase II clinical trial evaluating the combination of onapristone with anastrozole for women with hormone receptor positive endometrial cancer—Preliminary results. American Society of Clinical Oncology Annual Meeting, Chicago, IL 41 (suppl 16; abstr 5601): 2023.

Williams W, Dakhil SR, Calfa C, Holmes JP, Bhattacharya S, Lukas J, Tan-Chui E, Peoples G, Sunkar, V, Lacher, M., Wiseman, C.L: Overall survival following treatment with a modified whole tumor cell targeted immunotherapy in patients with advanced breast cancer. Cancer Research, San Antonio Breast Cancer Symposium, San Antonio, TX 82 (4_Supplement): P2-14-02,2022.

Tara Hyder, Saveri Bhattacharya, Kristine Gade, Azadeh Nasrazadani, Adam M Brufsky: Approaching Neoadjuvant Therapy in the Management of Early-Stage Breast Cancer Breast Cancer 30 (13): 199-211,2021.

Chun Wang, Zhaomei Mu, Zhong Ye, Zhenchao Zhang, Maysa M Abu-Khalaf, Daniel P Silver, Juan P Palazzo, Geetha Jagannathan, Frederick M Fellin, Saveri Bhattacharya, Rebecca J Jaslow, Theodore N Tsangaris, Adam Berger, Manish Neupane, Terrence P Cescon, AnaMaria Lopez, Kaelan Yao, Weelic Chong, Brian Lu, Ronald E Myers, Lifang Hou, Qiang Wei, Bingshan Li, Massimo Cristofanilli, Hushan Yang: Prognostic value of HER2 status on circulating tumor cells in advanced-stage breast cancer patients with HER2-negative tumors Breast Cancer Res Treat 181 (3): 2020.

William Williams, Shaker R. Dakhil, Carmen Julia Calfa, Jarrod P. Holmes, Saveri Bhattacharya, Jason Jerome Lukas, Elizabeth Tan-Chiu, George Earl Peoples, Vivekananda Sunkari, Markus Lacher, Charles L. Wiseman: Breast cancer grade and clinical benefit in patients with advanced breast cancer treated with an engineered whole tumor cell-targeted immunotherapy alone or in combination with checkpoint inhibition. American Society of Clinical Oncology Annual Meeting, Chicago, IL 38 (suppl; abstr 3033): 2020.

Lazar, M., Bhattacharya, S., Tsangaris, T.: Management of Recurrent and Metastatic Breast Cancer Breast Chapter in Current Surgical Therapy : 706-710,2020.

Bhattacharya, S., Schiewer, M., Murphy, R.C., Anne, P.R., Simone, N., Bar Ad, V., Abu Khalaf, M., Silver, D.P., Jaslow, R., Fellin, F.M., Zibelli, A.M., Lopez, A., Berger, A., Tsangaris, T.N., Lazar, M.A., Willis, A.I., Stauffer, P., Hurwitz, M.D. A: Pilot trial of Hyperthermia in Combination with Olaparib in Breast Cancer Patients with Chest wall Recurrences.” San Antonio Breast Cancer Symposium, San Antonio, TX : 2019.

Williams, W. V., Dakhil, D.S., Holmes, J.P. Bhattacharya, S., Calfa, C., Kundra, A., Adams, D., DaSilva, D., Cornfeld, M., Leopold, L., , Peoples, G.E., Sunkari, V., Lacher, M., Wiseman, C.L.: Efficacy and safety of a modified whole tumor cell targeted immunotherapy in patients with advanced breast cancer alone and in combination with immune checkpoint inhibitors" San Antonio Breast Cancer Symposium, San Antonio, TX : 2019.

Wesolowski, R., Brufsky, A., Chambers, M., Bhattacharya, S., Lustberg, M., VanDeusen, J. V., Sardesai, S., O Williams, N., Noonan, A.M., Phelps, M., Grever, M., Stephens, J., Carson, W.E., Ramaswamy, B.: Phase 1b study of heat shock protein 90 inhibitor, onalespib in combination with paclitaxel in patients with advanced, triple negative breast cancer NCT02474173). European Society of Medical Oncology Meeting, Barcelona, Spain : 2019.

Academic Contact Information

3400 Civic Center Blvd, 3rd floor, West Pavilion
Philadelphia, PA 19104
Phone: 215-615-5858
Patient appointments: 800-789-7366